xCella Biosciences Competitors and Similar CompaniesClear all
xCella Biosciences's competitors and similar companies include Puma Biotechnology, La Jolla Pharmaceutical Company, Replimune and Immuneering.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  La Jolla Pharmaceutical Company La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer. |  Immuneering Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases. | |||
Founding Date | Founding Date N/A | Founding Date 2010 | Founding Date 1989 | Founding Date 2015 | Founding Date 2008 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Menlo Park, US HQ | Locations Los Angeles, US HQ | Locations San Diego, US HQ San Diego, US San Diego, US | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Cambridge, US HQ New York, US San Diego, US |
Employees | Employees 1 | Employees 27214% decrease | Employees 9047% decrease | Employees 10422% increase | Employees 5320% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 136.8 m | Valuation ($) 171.2 m | Valuation ($) 823.3 m | Valuation ($) 58.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $75.7m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income $19.7m (FY, 2021) | Net income ($313.9m) (FY, 2026) | Net income ($56m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 12.1m | Total funding raised $ 172m | Total funding raised $ 22.9m | Total funding raised $ 30m | Total funding raised $ 57.2m |
For sources of this data, please see the company profile
View Company Profiles
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View companyLa Jolla Pharmaceutical Company
HQ
San Diego, US
Employees
90↓ 47% decrease
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
View company
Replimune
HQ
Woburn, US
Employees
104↑ 22% increase
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View companyImmuneering
HQ
Cambridge, US
Employees
53↓ 20% decrease
Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases.
View company